Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

[Medical awareness of risk factors of cardiovascular diseases in different types of hospitalized patients (part 2)].

Pogosova NV, Yufereva YM, Ausheva AK, Sokolova OY, Melik-Oganjanyan GY, Karpova AV, Arutyunov AA, Kalinina AS, Vygodin VA.

Kardiologiia. 2019 Jul 23;59(9S):31-41. doi: 10.18087/cardio.n470. Russian.

PMID:
31644415
2.

[The Possibility of Correcting Anxiety Symptoms in Cardiac Patients in Primary Care Settings: Results of the Therapeutic Part of a Russian Multicenter Study COMETA].

Pogosova NV, Yufereva YM, Ausheva AK, Kursakov AA, Arutyunov AA, Boytsov SA.

Kardiologiia. 2019 Sep 17;59(9):29-39. doi: 10.18087/cardio.2019.9.n468. Russian.

PMID:
31540574
3.

[Psychosocial Risk Factors in Patients With Most Common Cardiovascular Diseases Such as Hypertension and Coronary Artery Disease (Based on Results From the Russian Multicenter COMET Study)].

Pogosova NV, Sokolova OY, Yufereva YM, Kursakov AA, Ausheva AK, Arutyunov AA, Kalinina AS, Karpova AV, Vygodin VA, Boytsov SA, Oganov RG.

Kardiologiia. 2019 Aug 8;59(8):54-63. doi: 10.18087/cardio.2019.8.n469. Russian.

PMID:
31397230
4.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.

PMID:
31189511
5.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9.

PMID:
31189509
6.

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29.

PMID:
31152740
7.

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Cook Bruns N, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A, Parkhomenko AN, Ryden L, Pogosova N, Dans A, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne K, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Aug;157(2):403-412.e5. doi: 10.1053/j.gastro.2019.04.041. Epub 2019 May 2.

PMID:
31054846
8.

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Rydén L, Tokgözoğlu L, Wood D, De Bacquer D; EUROASPIRE V collaborators; Writing Committee; Scientific Steering/ Executive Committee; Coordinating centre; Diabetes centre; Data management centre; Statistical analysis centre; Central laboratory; Study centres, organisations, investigators and other research personnel (National Co-ordinators in each country are indicated by asterisk.

Atherosclerosis. 2019 Jun;285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014. Epub 2019 Apr 24.

PMID:
31054483
9.

Costs associated with cardiovascular disease create a significant burden for society and they seem to be globally underestimated.

Pogosova N.

Eur J Prev Cardiol. 2019 Jul;26(11):1147-1149. doi: 10.1177/2047487319842578. Epub 2019 Apr 6. No abstract available.

PMID:
30955346
10.

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.

Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, Maggioni A, Marques-Vidal P, Jennings C, Abreu A, Aguiar C, Badariene J, Bruthans J, Castro Conde A, Cifkova R, Crowley J, Davletov K, Deckers J, De Smedt D, De Sutter J, Dilic M, Dolzhenko M, Dzerve V, Erglis A, Fras Z, Gaita D, Gotcheva N, Heuschmann P, Hasan-Ali H, Jankowski P, Lalic N, Lehto S, Lovic D, Mancas S, Mellbin L, Milicic D, Mirrakhimov E, Oganov R, Pogosova N, Reiner Z, Stöerk S, Tokgözoğlu L, Tsioufis C, Vulic D, Wood D; EUROASPIRE Investigators*.

Eur J Prev Cardiol. 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.

11.

Psychosocial Risk Factors in Ambulatory Patients With Arterial Hypertension and Ischemic Heart Disease of 30 Cities in Russia: Data from the КОМЕТА (Сomet) Study.

Pogosova NV, Boitsov SA, Oganov RG, Kostyuk GP, Sokolova OY, Yufereva YM, Kursakov AA, Ausheva AK, Vygodin VA, Karpova AV, Arutyunov AА, Isakova SS.

Kardiologiia. 2018 Nov 23;58(11):5-16. doi: 10.18087/cardio.2018.11.10193. Russian.

PMID:
30625073
12.

[Preventive Counselling With the Use of Remote Technologies Provides Effective Control of Metabolic Risk Factors in Patients With High and Very High Cardiovascular Risk].

Pogosova NV, Yufereva YM, Yusubova AI, Allenov AM, Karpova AV, Ausheva AK, Pogozheva AV, Eganyan RA, Vygodin VA.

Kardiologiia. 2018 Oct;(10):34-44. Russian.

PMID:
30359215
13.

Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.

De Bacquer D, De Smedt D, Kotseva K, Jennings C, Wood D, Rydén L, Gyberg V, Shahim B, Amouyel P, Bruthans J, Castro Conde A, Cífková R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pajak A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D, Wagner M, De Backer G; EUROASPIRE Investigators.

Eur J Epidemiol. 2019 Mar;34(3):247-258. doi: 10.1007/s10654-018-0454-0. Epub 2018 Oct 23.

14.

[Clinical-Epidemiological Program of Studying Psychosocial Risk Factors in Cardiological Practice in Patients With Arterial Hypertension and Ischemic Heart Disease: First Results of a Multicenter Study in Russia].

Pogosova NV, Boytsov SA, Oganov RG, Yufereva YM, Kostyuk GP, Kursakov AA, Ausheva AK, Vygodin VA.

Kardiologiia. 2018 Sep;58(9):47-58. Russian.

PMID:
30295199
15.

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey.

De Smedt D, Annemans L, De Backer G, Kotseva K, Rydèn L, Wood D, Amouyel P, Bruthans J, Cifkova R, De Sutter J, Dolzhenko M, Erglis A, Gotcheva N, Gyberg V, Laucevicius A, Lovic D, Oganov R, Pajak A, Pogosova N, Reiner Ž, Stagmo M, De Bacquer D.

Int J Cardiol. 2018 Dec 1;272:20-25. doi: 10.1016/j.ijcard.2018.06.104. Epub 2018 Jun 28.

16.

Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trial.

Sharma M, Hart RG, Smith EE, Bosch J, Yuan F, Casanova A, Eikelboom JW, Connolly SJ, Wong G, Diaz R, Lopez-Jaramillo P, Ertl G, Störk S, Dagenais GR, Lonn EM, Ryden L, Tonkin AM, Varigos JD, Bhatt DL, Branch KR, Probstfield JL, Kim JH, Ha JW, O'Donnell M, Vinereanu D, Fox KA, Liang Y, Liu L, Zhu J, Pogosova N, Maggioni AP, Avezum A, Piegas LS, Keltai K, Keltai M, Cook Bruns N, Berkowitz S, Yusuf S.

Int J Stroke. 2019 Apr;14(3):270-281. doi: 10.1177/1747493018784478. Epub 2018 Jul 30.

PMID:
30058959
17.

Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study.

Langhorne P, O'Donnell MJ, Chin SL, Zhang H, Xavier D, Avezum A, Mathur N, Turner M, MacLeod MJ, Lopez-Jaramillo P, Damasceno A, Hankey GJ, Dans AL, Elsayed A, Mondo C, Wasay M, Czlonkowska A, Weimar C, Yusufali AH, Hussain FA, Lisheng L, Diener HC, Ryglewicz D, Pogosova N, Iqbal R, Diaz R, Yusoff K, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Magazi D, Nilanont Y, Rosengren A, Oveisgharan S, Yusuf S; INTERSTROKE collaborators.

Lancet. 2018 May 19;391(10134):2019-2027. doi: 10.1016/S0140-6736(18)30802-X. Epub 2018 May 17.

PMID:
29864018
18.

Potential and limitations of health policy to improve coronary heart disease prevention and to reduce the burden of disease: A Russian experience.

Pogosova N, Oganov R, Saner H, Suvorov S, Sokolova O.

Eur J Prev Cardiol. 2018 Nov;25(16):1725-1734. doi: 10.1177/2047487318768030. Epub 2018 Apr 11.

PMID:
29635927
19.

[Awareness of the Risk Factors for Cardiovascular Disease in Different Types of Hospitalized Medical Patients].

Pogosova NV, Lysenko MA, Samsonova IV, Karpova AV, Yufereva YM, Isakova SS, Vygodin VA, Vasilevskiy AS.

Kardiologiia. 2017 Dec;57(12):34-42. Russian.

PMID:
29466209
20.

[Efficiency of primary prevention for diseases caused by atherosclerosis in patients at high cardiovascular risk in Russia and other European countries (Part 2)].

Pogosova NV, Oganov RG, Boytsov SA, Ausheva AK, Sokolova OY, Kursakov AA, Pozdnyakov YM, Gomyranova NV, Karpova AV, Isakova SS, Salbieva AO, Yusubova AI, Gusarova TA, Lel'chuk IN, Allenov AM, Vinokurov VG, Strelkova SN, Klimova AO, Loshkarev YV, Rubanov RV.

Kardiologiia. 2017 Mar;57(S3):5-16. Russian.

PMID:
29466184

Supplemental Content

Loading ...
Support Center